Screening for sleep-disordered breathing: the continuing search for a reliable predictive questionnaire

See Articles page 742 exacerbationreduction, safe withdrawal of steroids, response to systemic steroids, and outcomes of acute exacerbations. Whether predicting risk of pneumonia can be added to this list remains to be seen. Blood eosinophils show promise to not only serve as a positive biomarker for predicting reduction in exacerbationswith inhaled corticosteroid therapy but also as a negative biomarker for predicting risk of pneumonia with such therapy; a true Janusof biomarkers.